drugset / Trial / NCT01681030

The Fibrin Pad Cardiovascular Study

NCT01681030

Phase 2 Completed 42 enrolled Ethicon, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a three-arm, randomized multicenter study evaluating the safety and effectiveness of EVARREST™ Fibrin Sealant Patch in controlling mild to moderate vascular anastomosis suture line bleeding in cardiovascular surgery.

Timeline

Start
2012-08-01
Primary completion
2013-08-01
Completion
2013-09-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Equine collagen Protein / enzyme biologic
Comparator Fibrinogen Concentrate Human Protein / enzyme biologic
Comparator Human Thrombin Protein / enzyme biologic